CAS: 767340-03-4 - (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine
Fórmula:C16H13F6N5O
InChI:InChI=1S/C16H13F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4-6H,1-3,7,23H2/b9-5-
Clave InChI:InChIKey=RLSFDUAUKXKPCZ-UITAMQMPSA-N
SMILES:O=C(C=C(N)CC1=CC(F)=C(F)C=C1F)N2CC3=NN=C(N3CC2)C(F)(F)F
- Sinónimos:
- (2Z)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one
- (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine
- (Z)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one
- 1,2,4-Triazolo[4,3-a]pyrazine, 7-[(2Z)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)-2-butenyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-
- 2-Buten-1-one, 3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (2Z)-
Sitagliptin Enamine ((Z)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one)
CAS:767340-03-4
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, …
Fórmula:
C16H13F6N5O
Forma y color:
Off-White Solid
Peso molecular:
405.10243
Entrega estimada en Estados Unidos, el Miércoles 22 de Mayo de 2024
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine
CAS:767340-03-4
Fórmula:
C16H13F6N5O
Pureza:
98%
Forma y color:
Solid
Peso molecular:
405.2977
Ref: AN-AG0036IO
1g | 50,00 € | |
5g | 70,00 € | |
10g | 112,00 € | |
25g | 181,00 € | |
100g | 603,00 € |
Entrega estimada en Estados Unidos, el Jueves 23 de Mayo de 2024
Sitagliptin Impurity 34
CAS:767340-03-4
Fórmula:
C16H13F6N5O
Forma y color:
White To Off-White Solid
Peso molecular:
405.30
Ref: 4Z-S-2011
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 24 de Mayo de 2024
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine
Producto controladoCAS:767340-03-4
Fórmula:
C16H13F6N5O
Forma y color:
Neat
Peso molecular:
405.30
Ref: 86-MM3378.20-0025
25mg | 696,00 € |
Entrega estimada en Estados Unidos, el Martes 28 de Mayo de 2024
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine
CAS:767340-03-4
Applications Sitagliptin intermediate. A dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of …
Fórmula:
C16H13F6N5O
Forma y color:
White
Peso molecular:
405.30
Ref: TR-O865000
5mg | 231,00 € | |
50mg | 1.606,00 € |
Entrega estimada en Estados Unidos, el Miércoles 3 de Julio de 2024
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine
CAS:767340-03-4
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine is a drug that has been studied in hemodialysis patients and found to reduce …
Fórmula:
C16H13F6N5O
Pureza:
Min. 95%
Forma y color:
White Off-White Powder
Peso molecular:
405.3 g/mol
Ref: 3D-FO155533
1g | 53,00 € | |
2g | 85,00 € | |
5g | 118,00 € | |
10g | 189,00 € | |
25g | 255,00 € |
Entrega estimada en Estados Unidos, el Viernes 5 de Julio de 2024